Obesity is accompanied by disturbances in peripheral glucocorticoid metabolism and changes in FA recycling

Obesity

Volumn 17, Issue 11, 2009, Pages 1982-1987

  Simonyte, Kotryna ^a   Rask, Eva ^b   Näslund, Ingmar ^b   Angelhed, Jan Erik ^c   Lönn, Lars ^d   Olsson, Tommy ^a   Mattsson, Cecilia ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; FATTY ACID; FATTY ACID SYNTHASE; GLUCOCORTICOID; LEPTIN; MESSENGER RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); STEROL REGULATORY ELEMENT BINDING PROTEIN;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; ARTICLE; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; INTRAABDOMINAL FAT; LIVER; METABOLISM; MIDDLE AGED; OBESITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WAIST CIRCUMFERENCE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSITY; ADULT; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRA-ABDOMINAL FAT; LEPTIN; LIVER; MIDDLE AGED; OBESITY; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEINS; SUBCUTANEOUS FAT, ABDOMINAL; WAIST CIRCUMFERENCE;

EID: 70350574080     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.99     Document Type: Article

References (41)

1. Wake DJ, Walker BR. 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Mol Cell Endocrinol 2004;215:45-54.
2. Seckl JR, Walker BR. Minireview: 11beta-hydroxysteroid dehydrogenase type 1-a tissue-specific amplifier of glucocorticoid action. Endocrinology 2001;142:1371-1376.
3. Tomlinson JW, Sinha B, Bujalska I, Hewison M, Stewart PM. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. J Clin Endocrinol Metab 2002;87:5630-5635.
4. Alberti L, Girola A, Gilardini L et al. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects. Int J Obes (Lond) 2007;31:1826-1831.
5. Lindsay RS, Wake DJ, Nair S et al. Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab 2003;88:2738-2744.
6. Rask E, Olsson T, Söderberg S et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001;86:1418-1421.
7. Rask E, Walker BR, Söderberg S et al. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 2002;87:3330-3336.
8. Wake DJ, Rask E, Livingstone DE et al. Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J Clin Endocrinol Metab 2003;88:3983-3988.
9. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC, Grino M. Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J Clin Endocrinol Metab 2002;87:2701-2705.
10. Michailidou Z, Jensen MD, Dumesic DA et al. Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity. Obesity (Silver Spring) 2007;15:1155-1163.
11. Mariniello B, Ronconi V, Rilli S et al. Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome. Eur J Endocrinol 2006;155:435-441.
12. Kannisto K, Pietiläinen KH, Ehrenborg E et al. Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins. J Clin Endocrinol Metab 2004;89:4414-4421.
13. Masuzaki H, Paterson J, Shinyama H et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-2170.
14. Paterson JM, Morton NM, Fievet C et al. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci USA 2004;101:7088-7093.
15. Morton NM, Holmes MC, Fiévet C et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 2001;276:41293-41300.
16. Livingstone DE, Jones GC, Smith K et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000;141:560-563.
17. Goedecke JH, Wake DJ, Levitt NS et al. Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women. Clin Endocrinol (Oxf) 2006;65:81-87.
18. Desbriere R, Vuaroqueaux V, Achard V et al. 11Beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. Obesity (Silver Spring) 2006;14:794-798.
19. Cassuto H, Kochan K, Chakravarty K et al. Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase in the liver via an extended glucocorticoid regulatory unit. J Biol Chem 2005;280:33873-33884.
20. Chakravarty K, Cassuto H, Reshef L, Hanson RW. Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C. Crit Rev Biochem Mol Biol 2005;40:129-154.
21. Chang TJ, Lee WJ, Chang HM, Lee KC, Chuang LM. Expression of subcutaneous adipose tissue phosphoenolpyruvate carboxykinase correlates with body mass index in nondiabetic women. Metab Clin Exp 2008;57:367-372.
22. Oberkofler H, Fukushima N, Esterbauer H, Krempler F, Patsch W. Sterol regulatory element binding proteins: relationship of adipose tissue gene expression with obesity in humans. Biochim Biophys Acta 2002;1575:75-81.
23. Kolehmainen M, Vidal H, Alhava E, Uusitupa MI. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity. Obes Res 2001;9:706-712.
24. Berthiaume M, Laplante M, Festuccia W et al. Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11beta-hydroxysteroid dehydrogenase type 1. Endocrinology 2007;148:2391-2397.
25. Gabrielsson BG, Olofsson LE, Sjögren A et al. Evaluation of reference genes for studies of gene expression in human adipose tissue. Obes Res 2005;13:649-652.
26. Lee MJ, Fried SK, Mundt SS et al. Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue. Obesity (Silver Spring) 2008;16:1178-1185.
27. Walker BR. 11Beta-hydroxysteroid dehydrogenase type 1 in obesity. Obes Res 2004;12:1-3.
28. Maffeis C, Manfredi R, Trombetta M et al. Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. J Clin Endocrinol Metab 2008;93:2122-2128.
29. Halleux CM, Servais I, Reul BA, Detry R, Brichard SM. Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity. J Clin Endocrinol Metab 1998;83:902-910.
30. Arner P. Regional differences in protein production by human adipose tissue. Biochem Soc Trans 2001;29:72-75.
31. Koh KK, Park SM, Quon MJ. Leptin and cardiovascular disease: response to therapeutic interventions. Circulation 2008;117:3238-3249.
32. Söderberg S, Ahrén B, Jansson JH et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999;246:409-418.
33. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005;288:H2031-H2041.
34. Bulló M, Salas-Salvadó J, García-Lorda P. Adiponectin expression and adipose tissue lipolytic activity in lean and obese women. Obes Surg 2005;15:382-386.
35. Sewter C, Berger D, Considine RV et al. Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-alpha. Diabetes 2002;51:1035-1041.
36. Berndt J, Kovacs P, Ruschke K et al. Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia 2007;50:1472-1480.
37. Gonzales LW, Ballard PL, Gonzales J. Glucocorticoid and cAMP increase fatty acid synthetase mRNA in human fetal lung explants. Biochim Biophys Acta 1994;1215:49-58.
38. Forest C, Tordjman J, Glorian M et al. Fatty acid recycling in adipocytes: a role for glyceroneogenesis and phosphoenolpyruvate carboxykinase. Biochem Soc Trans 2003;31:1125-1129.
39. Beale EG, Hammer RE, Antoine B, Forest C. Disregulated glyceroneogenesis: PCK1 as a candidate diabetes and obesity gene. Trends Endocrinol Metab 2004;15:129-135.
40. Beale EG, Harvey BJ, Forest C. PCK1 and PCK2 as candidate diabetes and obesity genes. Cell Biochem Biophys 2007;48:89-95.
41. Stimson RH, Andersson J, Andrew R et al. Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans. Diabetes 2009;58:46-53.